It’s not easy to get depression-detecting AI through the FDA

📰 The Verge

For the past seven years, the California-based startup Kintsugi has been developing AI designed to detect signs of depression and anxiety from a person's speech. But after failing to secure FDA clearance in time, the company is shutting down and releasing most of its technology as open-source. Some elements may even find a second life […]

Published 2 Apr 2026
Read full article → ← Back to News